Ivermectin – time for action - Hospital Pharmacy EuropeHospital Pharmacy Europe
Frontiers Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes - ScienceDirect
Largest Ivermectin Trial Fails to Show Benefit in COVID Outpatients
Ivermectin treatment in humans for COVID-19
Doctor who says he gave ivermectin to rural Alberta COVID-19 patients prompts warning from health authority
High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients
Ivermectin is ineffective in non-severe COVID-19 patients according to new study
Therapeutic advances in COVID-19
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Antiparasitic activity of ivermectin: Four decades of research into a “wonder drug” - ScienceDirect
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients, Virology Journal
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients, Virology Journal
Effect of Early Treatment with Ivermectin among Patients with Covid-19 : r/COVID19
